V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20028646 | 20012194 | null | 58.4 | Adjuvant (A) | 2016-08-03 | 2016-08-12 | FEC + DOCETAXEL | 2 | N | 20100934 | FEC + DOCETAXEL |
| 20028647 | 20012195 | 1.76 | 87.4 | Adjuvant (A) | 2014-04-29 | 2014-04-29 | FEC + DOCETAXEL | 02 | N | 20100937 | FEC + DOCETAXEL |
| 20028648 | 20012195 | 1.76 | 64.8 | Adjuvant (A) | 2018-01-14 | 2018-01-25 | FEC + DOCETAXEL | 02 | N | 20100937 | FEC + DOCETAXEL |
| 20028649 | 20012196 | 1.53 | 50.6 | Adjuvant (A) | 2016-11-01 | 2016-11-09 | FEC + DOCETAXEL | N | N | 20100946 | FEC + DOCETAXEL |
| 20028650 | 20012196 | 1.71 | 78.8 | Neo-adjuvant (N) | 2014-04-03 | 2014-04-03 | FEC + DOCETAXEL | 02 | N | 20100946 | FEC + DOCETAXEL |
| 20028651 | 20012197 | 1.6 | 106.8 | Adjuvant (A) | 2017-08-25 | 2017-09-04 | FEC + DOCETAXEL | 2 | N | 20100948 | FEC + DOCETAXEL |
| 20028652 | 20012197 | 1.69 | 95.45 | Neo-adjuvant (N) | 2013-02-27 | 2013-03-08 | FEC + DOCETAXEL | 02 | N | 20100948 | FEC + DOCETAXEL |
| 20028653 | 20012198 | 1.63 | 107.9 | Adjuvant (A) | 2014-10-28 | 2014-11-11 | FEC + DOCETAXEL | 02 | N | 20100953 | FEC + DOCETAXEL |
| 20028654 | 20012198 | 1.62 | 73 | Not known (9) | null | 2016-06-30 | FEC + DOCETAXEL | N | N | 20100953 | FEC + DOCETAXEL |
| 20028655 | 20012199 | null | null | Adjuvant (A) | 2014-09-25 | 2014-09-28 | FEC 100 + DOCETAXEL | 2 | N | 20100964 | FEC + DOCETAXEL |
| 20028656 | 20012199 | 1.67 | 68 | Adjuvant (A) | 2015-12-07 | 2016-03-12 | FEC + DOCETAXEL | 2 | N | 20100964 | FEC + DOCETAXEL |
| 20028657 | 20012200 | 1.54 | 80 | Adjuvant (A) | 2015-03-17 | 2015-04-01 | FEC + DOCETAXEL | N | N | 20100972 | FEC + DOCETAXEL |
| 20028658 | 20012200 | 1.64 | 70 | Adjuvant (A) | 2013-08-09 | 2013-08-28 | FEC + DOCETAXEL | N | N | 20100972 | FEC + DOCETAXEL |
| 20028659 | 20012200 | 1.5 | 71.4 | Adjuvant (A) | 2017-07-05 | 2017-07-12 | FEC + DOCETAXEL | N | N | 20100972 | FEC + DOCETAXEL |
| 20028660 | 20012201 | 1.63 | 63.7 | Adjuvant (A) | 2014-10-18 | 2014-11-12 | FEC + DOCETAXEL | Y | null | 20100988 | FEC + DOCETAXEL |
| 20028661 | 20012201 | 1.47 | 60.95 | Adjuvant (A) | 2016-09-11 | 2016-09-12 | FEC + DOCETAXEL | 02 | null | 20100988 | FEC + DOCETAXEL |
| 20028662 | 20012202 | 1.58 | 86.7 | Neo-adjuvant (N) | 2017-03-23 | 2017-04-06 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20100996 | FEC + DOCETAXEL |
| 20028663 | 20012202 | 1.66 | 97.2 | Adjuvant (A) | 2015-08-16 | 2015-10-05 | FEC + DOCETAXEL | N | N | 20100996 | FEC + DOCETAXEL |
| 20028664 | 20012203 | 1.57 | 83 | null | 2014-12-01 | 2014-12-19 | FEC + DOCETAXEL | N | N | 20101006 | FEC + DOCETAXEL |
| 20028665 | 20012204 | 1.65 | 73.8 | Curative (C) | 2016-02-02 | 2016-02-04 | FEC + DOCETAXEL | 02 | N | 20101007 | FEC + DOCETAXEL |
| 20028666 | 20012205 | 1.57 | 95.1 | Adjuvant (A) | 2016-11-22 | 2016-11-23 | FEC 100 + DOCETAXEL | 2 | Y | 20101008 | FEC + DOCETAXEL |
| 20028667 | 20012205 | 1.7 | 71.3 | Adjuvant (A) | 2016-01-26 | 2016-02-12 | FEC + DOCETAXEL | 02 | null | 20101008 | FEC + DOCETAXEL |
| 20028668 | 20012206 | 1.7 | 100 | Adjuvant (A) | 2014-09-07 | 2014-09-20 | FEC 100 + DOCETAXEL | 02 | N | 20101010 | FEC + DOCETAXEL |
| 20028669 | 20012206 | 1.68 | null | Adjuvant (A) | 2016-10-04 | 2016-11-03 | FEC + DOCETAXEL | N | N | 20101010 | FEC + DOCETAXEL |
| 20028670 | 20012207 | 1.57 | 77 | Neo-adjuvant (N) | 2013-11-28 | 2013-12-19 | FEC + DOCETAXEL | N | N | 20101018 | FEC + DOCETAXEL |
| 20028671 | 20012207 | 1.58 | 118.5 | Adjuvant (A) | 2013-08-17 | 2013-08-11 | FEC + DOCETAXEL | 02 | N | 20101018 | FEC + DOCETAXEL |
| 20028672 | 20012207 | 1.62 | 54.2 | Not known (9) | 2015-12-04 | 2015-12-07 | FEC + DOCETAXEL | 2 | N | 20101018 | FEC + DOCETAXEL |
| 20028673 | 20012208 | 1.63 | 58.5 | Adjuvant (A) | 2017-11-16 | 2017-12-17 | FEC + DOCETAXEL | 2 | N | 20101026 | FEC + DOCETAXEL |
| 20028674 | 20012208 | 1.61 | 60.5 | Adjuvant (A) | 2015-09-09 | 2015-09-30 | FEC + DOCETAXEL | 2 | N | 20101026 | FEC + DOCETAXEL |
| 20028675 | 20012209 | 1.56 | 94.4 | Adjuvant (A) | null | 2013-07-27 | FEC + DOCETAXEL | N | N | 20101031 | FEC + DOCETAXEL |
| 20028676 | 20012210 | 1.63 | 64 | Adjuvant (A) | 2015-06-25 | 2015-06-25 | FEC + DOCETAXEL | 02 | N | 20101033 | FEC + DOCETAXEL |
| 20028677 | 20012210 | 1.6 | 70 | null | 2013-09-27 | 2013-10-06 | FEC 100 + DOCETAXEL | 02 | null | 20101033 | FEC + DOCETAXEL |
| 20028678 | 20012210 | null | null | null | 2016-03-21 | 2016-03-27 | FEC + DOCETAXEL | N | null | 20101033 | FEC + DOCETAXEL |
| 20028679 | 20012210 | null | 79.7 | Neo-adjuvant (N) | 2015-05-20 | 2015-05-28 | FEC + DOCETAXEL | 02 | N | 20101033 | FEC + DOCETAXEL |
| 20028680 | 20012211 | 1.62 | null | Adjuvant (A) | 2015-04-11 | 2015-04-25 | FEC + DOCETAXEL | N | N | 20101050 | FEC + DOCETAXEL |
| 20028681 | 20012211 | 1.64 | 66 | Adjuvant (A) | 2013-09-21 | 2013-10-03 | FEC 100 + DOCETAXEL | 02 | N | 20101050 | FEC + DOCETAXEL |
| 20028682 | 20012212 | 1.58 | 74 | Adjuvant (A) | 2017-12-25 | 2017-12-27 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20101059 | FEC + DOCETAXEL |
| 20028683 | 20012213 | 1.7 | 70.4 | Adjuvant (A) | 2017-03-08 | 2017-03-31 | FEC + DOCETAXEL | 02 | N | 20101060 | FEC + DOCETAXEL |
| 20028684 | 20012214 | 1.62 | 109 | Neo-adjuvant (N) | 2014-03-16 | 2014-03-29 | FEC + DOCETAXEL | 02 | null | 20101062 | FEC + DOCETAXEL |
| 20028685 | 20012214 | 1.6 | null | Neo-adjuvant (N) | 2017-09-29 | 2017-10-01 | FEC + DOCETAXEL | N | N | 20101062 | FEC + DOCETAXEL |
| 20028686 | 20012215 | null | 49 | Adjuvant (A) | null | 2015-06-02 | FEC + DOCETAXEL | 2 | N | 20101066 | FEC + DOCETAXEL |
| 20028687 | 20012215 | 1.56 | 93.9 | Adjuvant (A) | 2015-07-07 | 2015-07-07 | FEC 100 + DOCETAXEL | 2 | N | 20101066 | FEC + DOCETAXEL |
| 20028688 | 20012216 | 1.73 | 77.3 | Adjuvant (A) | 2017-08-18 | 2017-08-31 | FEC 100 + DOCETAXEL | N | N | 20101068 | FEC + DOCETAXEL |
| 20028689 | 20012216 | 1.5 | 74.5 | Adjuvant (A) | 2014-11-14 | 2014-11-21 | FEC + DOCETAXEL | 02 | N | 20101068 | FEC + DOCETAXEL |
| 20028690 | 20109060 | 1.69 | 77 | Adjuvant (A) | 2016-06-25 | 2016-07-05 | FEC + DOCETAXEL | 02 | N | 20101075 | FEC + DOCETAXEL |
| 20028691 | 20109060 | 1.61 | 60 | Adjuvant (A) | 2016-03-03 | 2016-03-11 | FEC + DOCETAXEL | 02 | null | 20101075 | FEC + DOCETAXEL |
| 20028692 | 20012217 | 1.47 | null | Adjuvant (A) | 2017-11-06 | 2017-11-21 | FEC + DOCETAXEL | N | N | 20101089 | FEC + DOCETAXEL |
| 20028693 | 20012217 | null | null | Adjuvant (A) | 2015-07-23 | 2015-08-17 | FEC + DOCETAXEL | null | null | 20101089 | FEC + DOCETAXEL |
| 20028694 | 20012217 | null | null | Neo-adjuvant (N) | 2014-12-19 | 2015-01-16 | FEC + DOCETAXEL | N | N | 20101089 | FEC + DOCETAXEL |
| 20028695 | 20012217 | 1.68 | null | null | 2016-11-28 | 2016-12-14 | FEC 100 + DOCETAXEL | N | N | 20101089 | FEC + DOCETAXEL |